Diligence memo · auto-generated · as of July 2, 2026
Pradama Inc
Pradama Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Pradama Inc operates in Pharmaceuticals, based in LOUISVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pradama Inc has raised $550K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $300K on 2009-11-20.
Most recent recorded round closed around 2009-11-20.
Valuation (modeled)modeled
Provath models Pradama Inc at approximately $14M (range $168K–$161M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.86× the median modeled value of Pre-Seed Pharmaceuticals companies in 2007–2009 (21 peers) — value vs value, same stage and era. Within the normal band (86% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 16.6 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 13% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 23% of those peers.
Closest niche peers: Entopica Therapeutics, Inc., Pneumoflex Systems Llc, Anterion Therapeutics, Inc., Ikano Therapeutics Inc., Aiko Biotechnology Inc.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.